Economics of chronic heart failure.
Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1-2% and appears to be increasing, in part because of ageing of the population. Economic analyses of CHF should include both direct and indirect costs of care. Healthcare expenditure on CHF in developed countries consumes 1-2% of the total health care budget. The cost of hospitalization represents the greatest proportion of total expenditure. Optimization of drug therapy represents the most effective way of reducing costs. Recent economic analyses in the Netherlands and Sweden suggest the costs of care are rising.
Berry
C
C
MRC, Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, G12 8QQ, Glasgow, UK. colin.berry@clinmed.gla.ac.uk
Murdoch
D R
DR
McMurray
J J
JJ
D002908:Chronic Disease; D003365:Costs and Cost Analysis; D006333:Heart Failure / Q000191:economics* / Q000453:epidemiology; D006801:Humans